September 2023 – Page 3

Sep 28 2023

Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia

by Clinical Editor

No Comments

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, …

Sep 27 2023

Uncategorized

Will New Antipsychotics for Schizophrenia Be Game Changers?

by Clinical Editor

No Comments

Two new antipsychotics acting via novel mechanisms could be game changers in the treatment of schizophrenia. While ulotaront performed poorly in recent Phase 3 trials, KarXT is expected to receive...

Sep 27 2023

Uncategorized

New Schizophrenia Treatments Are Coming: Don’t Panic

by Clinical Editor

No Comments

At the recent Psych Congress 2023, a session titled “State of the Science: Focus on Schizophrenia” was presented by Peter J. Weiden, MD, a clinical professor of psychiatry at the...

Sep 27 2023

Uncategorized

New research identifies genetic links between schizophrenia and cardiovascular disease risk factors

by Clinical Editor

No Comments

New research finds that people with schizophrenia have a genetic propensity to smoking and a reduced genetic risk of obesity. The study, published in The American Journal of Psychiatry, revealed...

Sep 27 2023

Uncategorized

Brain damage linked to schizophrenia may spread as condition develops

by Clinical Editor

No Comments

Brain scans show loss of tissue starting in small areas when people first experience psychosis, and following neural highways until later it encompasses wider regions of the brain …

Sep 27 2023

Uncategorized

Schizophrenia Warning Signs: What to Look Out For

by Clinical Editor

No Comments

Overview A mental disorder characterized by delusions, hallucinations, disorganized thoughts, speech and behavior. Symptoms The symptoms of schizophrenia may vary depending on the individual and it …

Sep 26 2023

Uncategorized